FarmaMondo is proud to announce that its founder Yaron Spigel, co-founder Guy Jacoel and Board director Luciano Deportu have been confirmed as finalists in the “Visionary Entrepreneur” category of the EY Entrepreneur Of The Year™ in Switzerland programme, recognising leaders who are redefining industries through innovation, ambition and long-term impact.
The nomination reflects the founders’ shared vision of expanding patient access to medicines in markets where healthcare systems, infrastructure and commercial pathways can often limit availability. FarmaMondo has focused on helping pharmaceutical and biotechnology companies extend access to therapies beyond their existing footprint, acting as an extension of their business in markets where they lack direct presence.
“Yaron Spigel, Guy Jacoel and Luciano Deportu combine many years of international experience with entrepreneurial courage and complementary strengths. With FarmaMondo, they are building bridges between innovative therapies and patients in markets that have often not been well served.”
EY Entrepreneur Of The Year™ judges
This recognition reflects FarmaMondo’s ability to combine access expertise, patient identification, reimbursement and access capabilities and cross-functional execution within a single model. Together, these capabilities help pharmaceutical and biotechnology companies navigate complex healthcare environments and expand access to life-changing treatments to underserved patients globally.
Why it matters
Regulatory complexity, reimbursement hurdles, operational risk, and limited in-market infrastructure can all slow access to life-changing treatments. As a result, many pharmaceutical and biotechnology companies struggle to reach patients beyond their established footprint. FarmaMondo was established to address these challenges.
Today, FarmaMondo works with partners to identify patients and deliver structured access and commercialisation models in markets where they are not directly present. Stakeholders describe FarmaMondo as a trusted extension of their own teams, combining the agility of a specialist global organisation with the local capabilities and insights needed to navigate complex healthcare environments.
Looking ahead
The nomination recognises not only FarmaMondo’s growth journey, but also its commitment to ensuring that geography does not determine whether patients can access innovation.
FarmaMondo remains focused on helping innovative therapies reach the patients who need them most while supporting sustainable growth for its pharmaceutical and biotechnology partners.
****
About FarmaMondo Group:
FarmaMondo is a specialised international access and commercialisation partner working to unlock opportunities for patients and biotech and pharmaceutical alike. Providing tailored access based on local understanding and expertise, established networks, local funding knowledge, and trusted in-market execution to help bring therapies to patients and realize value in untapped markets.
Source references
EY World Entrepreneur Of The Year programme:
https://www.ey.com/en_ch/newsroom/2026/08/ey-entrepreneur-of-the-year-2026-the-finalists-have-been-confirmed-french-speaking-switzerland-ticino-and-central-switzerland-heavily-represented
